UBS O'Connor’s Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share FSNB.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding FSNB.WS
RCM
SCM
SIA
ETH
GAM
SBLIC
DCM
SMA
RCM
UBS O'Connor's FSNB.WS Position: Q4 2022 in Review
UBS O'Connor sold out of Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share (FSNB.WS) in Q4 2022, closing a stake of 237,958 shares — an estimated $15K sold.
UBS O'Connor first reported a position in FSNB.WS in Q2 2022 and held it in 2 quarters. The position peaked at $28K in Q2 2022. 15 funds tracked by Wall St. Rank hold FSNB.WS as of Q4 2022.
- UBS O'Connor reported no remaining Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
- UBS O'Connor sold 237,958 Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share shares in Q4 2022, an estimated $15K.
- UBS O'Connor first reported a position in Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share in Q2 2022 and held it in 2 quarters.
- UBS O'Connor's Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share position peaked at $28K in Q2 2022.
- 15 funds tracked by Wall St. Rank held Fusion Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share as of Q4 2022.
Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.